Table 3 Association of budding counts with clinicopathological features.
From: Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups
Feature | ITBCC (mean) | P value |
|---|---|---|
T stage | ||
T1 | 0.6 | <0.0001 |
T2 | 0.5 | |
T3 | 1.6 | |
T4 | 4 | |
Grading | ||
G1 | 0.3 | 0.0036 |
G2 | 0.6 | |
G3 | 1.5 | |
MELF pattern | ||
0 | 0.56 | 0.001 |
1 | 1.3 | |
N stage | ||
N0 | 0.6 | 0.0004 |
N1 | 1.4 | |
M stage | ||
M0 | 0.7 | 0.0292 |
M1 | 1.5 | |
L stage | ||
L0 | 0.5 | <0.0001 |
L1 | 1.4 | |
V stage | ||
V0 | 0.6 | 0.0134 |
V1 | 1.1 | |
Recurrence | ||
None | 0.6 | 0.0105 |
Yes | 0.9 | |
